
  
    
      
        Introduction_NNP
        The_DT association_NN of_IN inhaled_JJ particulate_NN pollution_NN and_CC
        cigarette_NN smoking_NN with_IN pulmonary_JJ disease_NN ,_, such_JJ as_IN chronic_JJ
        obstructive_JJ pulmonary_JJ disease_NN ,_, is_VBZ well_RB documented_VBN [_NN 1_CD ]_NN ,_,
        but_CC the_DT specific_JJ early_JJ responses_NNS of_IN lung_NN epithelial_NN cells_NNS
        to_TO toxic_JJ substances_NNS in_IN particulates_NNS -_: that_WDT predispose_VB the_DT
        cells_NNS to_TO disease_NN -_: have_VBP not_RB been_VBN elucidated_JJ ._. Cigarette_NNP
        smoke_NN has_VBZ also_RB been_VBN considered_VBD a_DT major_JJ player_NN in_IN the_DT
        pathogenesis_NNS of_IN asthma_NN and_CC as_IN a_DT trigger_NN for_IN acute_JJ symptoms_NNS
        [_NN 2_CD ]_NN ._. Exposure_NNP to_TO cigarette_NN smoke_NN activates_NNS an_DT
        inflammatory_JJ cascade_NN in_IN the_DT airway_NN epithelium_NN resulting_VBG in_IN
        the_DT production_NN of_IN a_DT number_NN of_IN potent_JJ cytokines_NNS and_CC
        chemokines_NNS ,_, with_IN accompanying_VBG damage_NN to_TO the_DT lung_NN
        epithelium_NN ,_, increased_VBN permeability_NN ,_, and_CC recruitment_NN of_IN
        macrophages_NNS and_CC neutrophils_NNS to_TO the_DT airway_NN [_NN 3_CD ]_NN ._. Even_RB
        brief_JJ exposure_NN to_TO cigarette_NN smoke_NN has_VBZ been_VBN shown_VBN to_TO
        increase_VB expression_NN of_IN IL-_NNP 8_CD in_IN primary_JJ cultures_NNS of_IN human_JJ
        bronchial_NN epithelial_NN cells_NNS (_( HBEs_NNP )_) in_IN the_DT presence_NN of_IN dust_NN
        mite_NN allergen_NN [_NN 4_CD ]_NN ._. Increased_VBN release_NN of_IN the_DT chemokine_NN
        IL-_NNP 8_CD has_VBZ also_RB been_VBN shown_VBN for_IN cultured_JJ HBEs_NNP exposed_VBD to_TO
        cigarette_NN smoke_NN extract_NN (_( CSE_NNP )_) [_NN 5_CD 6_CD ]_NN and_CC diesel_NN exhaust_NN
        particles_NNS [_NN 7_CD ]_NN ._. However_RB ,_, the_DT precise_JJ molecular_JJ events_NNS
        that_WDT bring_VBP about_IN these_DT intracellular_NN changes_NNS and_CC acute_JJ
        inflammation_NN in_IN lung_NN epithelial_NN cells_NNS are_VBP not_RB well_RB
        understood_VBN ._.
        Upregulation_NNP of_IN cytokine_NN gene_NN expression_NN in_IN epithelial_NN
        cells_NNS has_VBZ been_VBN linked_VBN to_TO activation_NN of_IN specific_JJ signaling_VBG
        pathways_NNS ._. Involvement_NNP of_IN the_DT mitogen-activated_JJ protein_NN
        kinase_NN (_( MAPK_NNP )_) pathway_NN ,_, extracellular_NN signal-regulated_JJ
        protein_NN kinase_NN (_( ERK_NNP )_) -_: 1_CD /_NN 2_CD (_( p_NN 44_CD /_NN p_NN 42_CD )_) ,_, in_IN cytokine_NN regulation_NN
        has_VBZ been_VBN demonstrated_VBN in_IN HBEs_NNP exposed_VBD to_TO diesel_NN exhaust_NN
        particles_NNS [_NN 7_CD ]_NN but_CC not_RB to_TO cigarette_NN smoke_NN ._. NFκB_NNP is_VBZ a_DT
        ubiquitous_JJ transcription_NN factor_NN involved_VBN in_IN regulating_VBG
        inflammatory_JJ responses_NNS ,_, and_CC its_PRP$ targets_NNS include_VBP several_JJ of_IN
        the_DT genes_NNS encoding_VBG cytokines_NNS and_CC chemokines_NNS ._. The_DT activation_NN
        of_IN NFκB_NNP by_IN oxidative_JJ stress_NN ,_, inflammatory_JJ cytokines_NNS such_JJ as_IN
        IL-_NNP 1_CD β_NN and_CC by_IN TNF-α_NNP has_VBZ been_VBN studied_VBN in_IN depth_NN [_NN 8_CD ]_NN ,_, but_CC
        much_RB less_JJR is_VBZ known_VBN about_IN the_DT effects_NNS of_IN cigarette_NN smoke_NN on_IN
        NFκB_NNP activation_NN ._.
        The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO gain_VB insight_NN into_IN the_DT
        mechanism_NN of_IN inflammation_NN induced_VBN by_IN cigarette_NN smoke_NN ,_,
        specifically_RB the_DT acute_JJ response_NN to_TO smoke_VB ._. The_DT human_JJ
        alveolar_NN epithelial_NN cell_NN line_NN A_DT 549_CD and_CC normal_JJ human_JJ
        bronchial_NN epithelial_NN cells_NNS (_( NHBEs_NNP )_) were_VBD exposed_VBN to_TO the_DT
        particulate_NN fraction_NN of_IN cigarette_NN smoke_NN (_( cigarette_NN smoke_NN
        condensate_NN ;_: CSC_NNP )_) and_CC examined_VBD for_IN the_DT production_NN of_IN
        proinflammatory_NN cytokines_NNS and_CC activation_NN of_IN MAPK_NNP and_CC NFκB_NNP ._.
        The_DT results_NNS demonstrate_VBP that_IN the_DT acute_JJ phase_NN response_NN of_IN
        pulmonary_JJ epithelial_NN cells_NNS to_TO cigarette_NN smoke_NN involves_VBZ
        activation_NN of_IN ERK_NNP 1_CD /_NN 2_CD and_CC NFκB_NNP
      
      
        Materials_NNS and_CC methods_NNS
        
          Reagents_NNP
          RPMI_NNP 1640_CD ,_, penicillin_NN ,_, streptomycin_NN ,_, fungizone_NN ,_, and_CC
          trypsin_NN /_NN EDTA_NNP were_VBD obtained_VBN from_IN Cellgro_NNP (_( Herndon_NNP ,_, VA_NNP ,_,
          USA_NNP )_) ._. Fetal_NNP bovine_JJ serum_NN was_VBD from_IN Atlanta_NNP Biochemicals_NNP
          (_( Atlanta_NNP ,_, GA_NNP ,_, USA_NNP )_) ._. The_DT culture_NN medium_NN (_( BEGM_NNP )_) ,_, growth_NN
          factors_NNS ,_, trypsin_NN ,_, trypsin_NN neutralizing_VBG solution_NN ,_, and_CC
          Hanks_NNP '_POS balanced_JJ salt_NN solution_NN for_IN growing_VBG and_CC treating_VBG
          primary_JJ human_JJ epithelial_NN cells_NNS were_VBD purchased_VBN from_IN
          Clonetics_NNP (_( San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP ._. CSC_NNP was_VBD purchased_VBN from_IN
          Murty_NNP Pharmaceuticals_NNP (_( Lexington_NNP ,_, KY_NNP ,_, USA_NNP )_) and_CC was_VBD
          prepared_VBN using_VBG a_DT Phipps-_NNP Bird_NNP 20_CD -_: channel_NN smoking_NN machine_NN
          designed_VBN for_IN FTC_NNP testing_NN ._. The_DT particulate_NN matter_NN from_IN
          Kentucky_NNP standard_JJ cigarettes_NNS (_( 1_CD R_NN 3_CD F_NN ;_: University_NNP of_IN
          Kentucky_NNP ,_, KY_NNP ,_, USA_NNP )_) was_VBD collected_VBN on_IN Cambridge_NNP glass_NN fibre_NN
          filters_NNS and_CC the_DT amount_NN obtained_VBN determined_VBN by_IN weight_NN
          increase_NN of_IN the_DT filter_NN ._. CSC_NNP was_VBD prepared_VBN by_IN dissolving_VBG
          the_DT collected_VBN smoke_NN particulates_NNS in_IN dimethyl_NN sulfoxide_NN
          (_( DMSO_NNP )_) to_TO yield_VB a_DT 4_CD %_NN solution_NN (_( w_NN /_NN v_NN )_) ._. The_DT average_JJ yield_NN of_IN
          CSC_NNP was_VBD 26_CD ._. 1_LS mg_NN /_NN cigarette_NN ._. The_DT CSC_NNP was_VBD diluted_VBN into_IN DMSO_NNP
          and_CC aliquots_NNS were_VBD kept_VBN at_IN -_: 80_CD °_NN C_NNP ._. Oligonucleotide_NNP primers_NNS
          for_IN PCR_NNP were_VBD synthesized_JJ by_IN Operon_NNP Technologies_NNPS (_( Alameda_NNP ,_,
          CA_NNP ,_, USA_NNP )_) ._. Taq_NNP polymerase_NN ,_, deoxynucleotide_NN triphosphates_NNS
          and_CC Taq_NNP buffer_NN were_VBD from_IN Promega_NNP (_( Madison_NNP ,_, WI_NNP ,_, USA_NNP )_) ._.
          Anti-_NNP ERK_NNP 1_CD /_NN 2_CD (_( p_NN 44_CD /_NN p_NN 42_CD )_) polyclonal_NN antibody_NN ,_,
          anti-phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD polyclonal_NN antibody_NN ,_, and_CC
          horseradish_NN peroxidase_NN (_( HRP_NNP )_) -_: conjugated_JJ goat_NN anti-rabbit_JJ
          IgG_NNP were_VBD purchased_VBN from_IN New_NNP England_NNP Biolabs_NNP (_( Beverly_NNP ,_, MA_NNP ,_,
          USA_NNP )_) ._. Anti-phosphorylated_NNP IκB-α_NNP polyclonal_NN antibody_NN ,_, IκB_NNP
          monoclonal_NN antibody_NN and_CC chemiluminescent_NN detection_NN
          reagents_NNS were_VBD from_IN Cell_NNP Signaling_NNP Technology_NNP (_( Beverly_NNP ,_,
          MA_NNP ,_, USA_NNP )_) ._.
        
        
          Cell_NNP culture_NN
          The_DT human_JJ alveolar_NN epithelial_NN cell_NN line_NN A_DT 549_CD (_( ATCC_NNP ,_,
          Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_) was_VBD grown_VBN in_IN RPMI_NNP plus_CC 10_CD %_NN fetal_JJ
          bovine_JJ serum_NN ,_, 100_CD U_NNP /_NN ml_NN penicillin_NN ,_, 100_CD U_NNP /_NN ml_NN streptomycin_NN ,_,
          and_CC 250_CD ng_NN /_NN ml_NN amphotericin-_NN B_NNP in_IN an_DT atmosphere_NN of_IN 5_CD %_NN
          carbon_NN dioxide_NN and_CC 95_CD %_NN air_NN at_IN 37_CD °_NN C_NNP ._. Primary_JJ cultures_NNS of_IN
          NHBEs_NNP (_( Clonetics_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) were_VBD obtained_VBN at_IN
          second_JJ passage_NN and_CC cultured_JJ according_VBG to_TO the_DT
          manufacturer_NN 's_POS instructions_NNS using_VBG the_DT media_NNS and_CC growth_NN
          factors_NNS supplied_VBN with_IN the_DT cells_NNS ._. The_DT cells_NNS were_VBD seeded_VBN
          into_IN 12_CD -_: well_RB culture_NN plates_NNS at_IN 10_CD 5_CD cells_NNS per_IN well_RB and_CC
          used_VBN between_IN passages_NNS three_CD and_CC seven_CD ._.
        
        
          Exposure_NNP of_IN epithelial_NN cells_NNS to_TO cigarette_NN smoke_NN
          condensate_NN
          Cultures_NNP of_IN A_DT 549_CD cells_NNS or_CC NHBEs_NNP were_VBD grown_VBN to_TO 50_CD -_: 75_CD %_NN
          confluence_NN ,_, then_RB incubated_JJ with_IN serum-deficient_JJ media_NNS for_IN
          4_CD hours_NNS before_IN exposure_NN to_TO CSC_NNP ._. Treatment_NNP with_IN CSC_NNP ,_, at_IN a_DT
          final_JJ concentration_NN of_IN 0_CD ._. 4_CD μg_NN /_NN ml_NN in_IN 0_CD ._. 5_CD %_NN DMSO_NNP ,_, was_VBD
          carried_VBN out_IN in_IN modified_VBN Eagle_NNP 's_POS medium_NN (_( MEM_NNP )_) containing_VBG
          Earle_NNP 's_POS salts_NNS at_IN 37_CD °_NN C_NNP for_IN 30_CD min_NN to_TO 5_CD hours_NNS ._. Control_NN
          cells_NNS were_VBD treated_VBN with_IN the_DT same_JJ concentration_NN of_IN DMSO_NNP
          without_IN CSC_NNP ._. For_IN CSC_NNP dose-response_JJ experiments_NNS ,_, cells_NNS
          were_VBD incubated_JJ for_IN 30_CD min_NN at_IN 37_CD °_NN C_NNP with_IN concentrations_NNS of_IN
          CSC_NNP ranging_VBG from_IN 0_CD ._. 004_CD to_TO 20_CD μg_NN /_NN ml_NN in_IN 0_CD ._. 5_CD %_NN DMSO_NNP ._. Cell_NNP
          viability_NN after_IN CSC_NNP treatment_NN was_VBD determined_VBN using_VBG the_DT
          trypan_NN blue_JJ dye_NN exclusion_NN test_NN and_CC was_VBD compared_VBN to_TO
          viability_NN of_IN untreated_JJ control_NN cells_NNS ._.
        
        
          TUNEL_NNP assay_NN
          The_DT induction_NN of_IN apoptosis_NNS was_VBD determined_VBN by_IN means_NNS of_IN
          the_DT TUNEL_NNP (_( deoxynucleotidyl_NN transferase-mediated_JJ dUTP_NN
          nick_NN end_NN labeling_VBG )_) assay_NN using_VBG a_DT kit_NN supplied_VBN by_IN Promega_NNP
          (_( Madison_NNP ,_, WI_NNP ,_, USA_NNP )_) ._. Cultures_NNP of_IN A_DT 549_CD cells_NNS or_CC NHBEs_NNP were_VBD
          grown_VBN on_IN 8_CD -_: well_RB slides_VBZ and_CC treated_VBN with_IN CSC_NNP as_IN described_VBN
          above_IN ,_, fixed_VBN with_IN 4_CD %_NN paraformaldehyde_NN for_IN 15_CD min_NN at_IN room_NN
          temperature_NN ,_, then_RB examined_VBN by_IN fluorescent_NN microscopy_NN ._.
          Nuclei_NNP were_VBD counterstained_JJ by_IN the_DT addition_NN of_IN
          4_CD '_POS ,_, 6_CD -_: diamidino-_NN 2_CD -_: phenylindole_NN dihydrochloride_NN (_( DAPI_NNP ;_:
          Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP ,_, USA_NNP )_) to_TO the_DT mounting_VBG
          medium_NN ._. The_DT percentage_NN of_IN apoptotic_JJ cells_NNS was_VBD determined_VBN
          by_IN counting_VBG green_JJ fluorescent_NN nuclei_NN relative_JJ to_TO the_DT
          total_JJ number_NN of_IN DAPI-positive_NNP nuclei_NN ._.
        
        
          Reverse-transcriptase_NNP PCR_NNP
          A_DT 549_CD cells_NNS or_CC NHBEs_NNP were_VBD grown_VBN to_TO approximately_RB 75_CD %_NN
          confluence_NN in_IN 12_CD -_: well_RB plates_NNS ,_, treated_VBN with_IN various_JJ
          concentrations_NNS of_IN CSC_NNP in_IN 0_CD ._. 5_CD %_NN DMSO_NNP ,_, and_CC total_JJ RNA_NNP was_VBD
          isolated_VBN using_VBG RNeasy_NNP method_NN (_( Qiagen_NNP ,_, Valencia_NNP ,_, CA_NNP ,_, USA_NNP )_) ._.
          RNA_NNP (_( 1_CD μg_NN )_) was_VBD converted_VBN to_TO cDNA_NN in_IN a_DT 50_CD μl_NN reaction_NN
          containing_VBG 1_CD U_NNP of_IN avian_NN myeloblastosis_NNS virus_NN reverse_NN
          transcriptase_NN (_( New_NNP England_NNP Biolabs_NNP ,_, Beverly_NNP ,_, MA_NNP ,_, USA_NNP )_) ,_, 1_CD
          mM_NN dNTP_NN 's_POS ,_, and_CC 10_CD μg_NN /_NN ml_NN random_JJ hexamer_NN primers_NNS in_IN 1_CD ×_NN
          reverse_NN transcriptase_NN buffer_NN at_IN 42_CD °_NN C_NNP for_IN 50_CD min_NN ;_: the_DT
          reaction_NN was_VBD terminated_VBN by_IN heating_VBG to_TO 90_CD °_NN C_NNP for_IN 10_CD min_NN ._.
          The_DT resulting_VBG cDNA_NN was_VBD used_VBN as_IN template_NN for_IN PCR_NNP
          amplification_NN using_VBG the_DT primer_NN pairs_NNS (_( Operon_NNP
          Technologies_NNPS ,_, Alameda_NNP ,_, CA_NNP ,_, USA_NNP )_) listed_VBN in_IN Table_NNP 1_CD ._. As_IN a_DT
          loading_NN control_NN parallel_JJ PCR_NNP reactions_NNS were_VBD carried_VBN out_IN
          using_VBG a_DT primer_NN pair_NN for_IN human_JJ GAPDH_NNP (_( see_VB Table_NNP 1_LS )_) ._. PCR_NNP
          products_NNS were_VBD separated_JJ on_IN agarose_NN gels_NNS ,_, the_DT ethidium_NN
          bromide-stained_JJ bands_NNS were_VBD digitally_RB photographed_VBN using_VBG a_DT
          ChemImager_NNP 4400_CD (_( Alpha_NNP Inotech_NNP ,_, San_NNP Leandro_NNP ,_, CA_NNP ,_, USA_NNP )_) and_CC
          scanned_JJ using_VBG the_DT AphaEase_NNP version_NN 5_CD ._. 5_CD densitometry_NN
          program_NN ._. The_DT experimental_JJ values_NNS were_VBD normalized_JJ to_TO the_DT
          corresponding_JJ GAPDH_NNP value_NN and_CC expressed_VBD as_IN relative_JJ
          intensity_NN ._.
        
        
          Western_NNP blotting_VBG and_CC immunocytochemistry_NN
          A_DT 549_CD cells_NNS or_CC NHBEs_NNP were_VBD treated_VBN with_IN CSC_NNP as_IN described_VBN
          above_IN and_CC whole-cell_JJ protein_NN extracts_NNS were_VBD prepared_VBN by_IN
          scraping_VBG cells_NNS into_IN lysis_NNS buffer_NN containing_VBG 20_CD mM_NN
          Tris-_NNP HCl_NNP (_( pH_NN 8_CD ._. 0_CD )_) ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN sodium_NN orthovanadate_NN ,_,
          1_CD mM_NN sodium_NN fluoride_NN ,_, 1_CD μg_NN /_NN ml_NN each_DT of_IN leupeptin_NN and_CC
          pepstatin_NN ,_, and_CC 1_CD μM_NN PMSF_NNP ._. Cell_NNP lysis_NNS was_VBD achieved_VBN by_IN
          sonicating_VBG the_DT suspension_NN on_IN ice_NN with_IN three_CD 10_CD -_: second_JJ
          bursts_NNS at_IN a_DT power_NN setting_VBG of_IN 2_CD mW_NN (_( Sonic_NNP Dismembrator_NNP ,_,
          Fisher_NNP Scientific_NNP Co_NNP ._. ,_, Atlanta_NNP ,_, GA_NNP ,_, USA_NNP )_) ._. Lysates_NNP were_VBD
          clarified_VBN by_IN centrifugation_NN at_IN 10_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 30_CD min_NN at_IN 4_CD °_NN C_NNP and_CC the_DT protein_NN
          concentration_NN of_IN the_DT whole-cell_JJ extracts_NNS was_VBD determined_VBN
          by_IN the_DT bicinchoninic_JJ protein_NN assay_NN (_( Pierce_NNP Biochemical_NNP
          Co_NNP ._. ,_, Rockford_NNP ,_, IL_NNP ,_, USA_NNP )_) ._. Aliquots_NNP of_IN 10_CD μg_NN of_IN protein_NN
          were_VBD separated_VBN by_IN SDS-PAGE_NNP and_CC electroblotted_JJ to_TO
          nitrocellulose_NN ._. The_DT filters_NNS were_VBD blocked_VBN with_IN 2_CD %_NN nonfat_JJ
          dry_JJ milk_NN in_IN 10_CD mM_NN Tris-_NNP HCl_NNP (_( pH_NN 8_CD ._. 0_CD )_) ,_, 0_CD ._. 15_CD M_NNP sodium_NN
          chloride_NN ,_, 0_CD ._. 2_CD %_NN Tween-_NNP 20_CD (_( TBST_NNP )_) then_RB incubated_JJ with_IN
          primary_JJ antibody_NN (_( 1_CD :_: 1000_CD dilution_NN )_) for_IN 2_CD hours_NNS at_IN room_NN
          temperature_NN ._. After_IN washing_VBG in_IN Tris-buffered_NNP saline_NN with_IN
          tween_NN 20_CD (_( TBST_NNP )_) ,_, blots_NNS were_VBD incubated_JJ for_IN one_CD hour_NN at_IN
          room_NN temperature_NN with_IN HRP-conjugated_NNP secondary_JJ antibody_NN ,_,
          washed_VBD again_RB and_CC detected_VBN by_IN chemiluminescence_NN ._. The_DT
          protein_NN bands_NNS were_VBD quantified_VBN by_IN densitometry_NN as_IN
          described_VBN above_IN ._. For_IN immunocytochemistry_NN ,_, NHBEs_NNP grown_VBN on_IN
          8_CD -_: well_RB chamber_NN slides_NNS were_VBD exposed_VBN to_TO CSC_NNP at_IN a_DT
          concentration_NN of_IN 0_CD ._. 4_CD μg_NN /_NN ml_NN for_IN 30_CD min_NN ._. Cells_NNP were_VBD fixed_VBN
          with_IN 4_CD %_NN paraformaldehyde_NN ,_, blocked_VBN with_IN BSA_NNP ,_, immunostained_JJ
          using_VBG anti-phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD ,_, and_CC visualized_JJ using_VBG
          HRP-conjugated_NNP secondary_JJ antibody_NN and_CC bisbenzamidine_NN
          substrate_NN ._.
        
        
          Transfection_NNP with_IN NFκB-luciferase_NNP reporter_NN
          constructs_NNS and_CC assay_NN for_IN gene_NN expression_NN
          A_DT 549_CD cells_NNS were_VBD grown_VBN to_TO 50_CD -_: 80_CD %_NN confluence_NN on_IN 12_CD -_: well_RB
          plates_NNS and_CC transfected_JJ with_IN the_DT Mercury_NNP pathway_NN profiling_VBG
          system_NN vector_NN ,_, pNFκB-TA-Luc_JJ (_( Clontech_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP ,_,
          USA_NNP )_) ,_, using_VBG lipofectamine_NN (_( Gibco_NNP /_NN BRL_NNP ,_, Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_)
          and_CC used_VBN according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._.
          Cells_NNP were_VBD transfected_JJ using_VBG lipofectamine_NN from_IN Bibco_NNP /_NN BRL_NNP
          (_( Rockville_NNP ,_, MD_NNP )_) ._. The_DT plasmid_NN ,_, pVAX-LacZ_JJ ,_, (_( Clontech_NNP ,_, Palo_NNP
          Alto_NNP ,_, CA_NNP ,_, USA_NNP )_) was_VBD used_VBN as_IN transfection_NN control_NN ._.
          DNA_NN /_NN lipofectamine_NN complexes_NNS were_VBD allowed_VBN to_TO form_VB for_IN
          30_CD min_NN at_IN room_NN temperature_NN in_IN RPMI_NNP (_( without_IN antibiotics_NNS )_)
          containing_VBG 1_CD μg_NN of_IN reporter_NN plasmid_NN ,_, 20_CD ng_NN of_IN pVAX-LacZ_JJ
          for_IN monitoring_VBG transfection_NN efficiency_NN ,_, and_CC 10_CD μg_NN of_IN
          lipofectamine_NN ._. Cells_NNP were_VBD transfected_JJ for_IN 18_CD h_NN ._. Prior_RB to_TO
          CSC_NNP challenge_NN ,_, the_DT transfected_JJ cells_NNS were_VBD preincubated_JJ
          for_IN 4_CD hours_NNS in_IN minimal_JJ Eagle_NNP 's_POS medium_NN with_IN Earle_NNP 's_POS salts_NNS
          to_TO remove_VB serum_NN factors_NNS ._. Assays_NNP were_VBD done_VBN in_IN triplicate_NN
          and_CC consisted_VBD of_IN untreated_JJ controls_NNS ,_, treatment_NN with_IN 50_CD
          ng_NN /_NN ml_NN TNF-α_NNP and_CC treatment_NN with_IN 0_CD ._. 4_CD μg_NN /_NN ml_NN CSC_NNP ._. After_IN
          treatments_NNS ,_, the_DT cells_NNS were_VBD lysed_JJ by_IN addition_NN of_IN cell_NN
          lysis_NNS buffer_NN as_IN supplied_VBN in_IN the_DT luciferase_NN assay_NN kit_NN from_IN
          Clontech_NNP ,_, scraped_JJ from_IN the_DT wells_NNS and_CC centrifuged_JJ 1_CD min_NN at_IN
          12_CD ,_, 000_CD ×_NN 
          g_SYM ._. Aliquots_NNP of_IN 20_CD μl_NN of_IN each_DT lysate_NN
          were_VBD transferred_VBN to_TO flat-bottomed_JJ ,_, white_JJ microtiter_NN
          plates_NNS (_( Dynex_NNP ,_, Chantilly_NNP ,_, VA_NNP ,_, USA_NNP )_) and_CC read_VB on_IN a_DT Dynex_NNP
          MLX_NNP plate_NN reader_NN in_IN flash_VBP mode_NN ._. The_DT transfection_NN
          efficiency_NN was_VBD normalized_JJ by_IN determining_VBG β-galactosidase_JJ
          activity_NN in_IN the_DT lysates_NNS from_IN the_DT cotransfected_JJ pLacZ_NN
          plasmid_NN ._.
        
        
          Statistical_NNP Analysis_NNP
          All_DT values_NNS are_VBP expressed_VBN as_IN mean_NN ±_NN standard_JJ error_NN of_IN
          the_DT mean_NN (_( SEM_NNP )_) ._. Comparisons_NNP of_IN experimental_JJ values_NNS for_IN
          CSC-treated_NNP cells_NNS to_TO untreated_JJ controls_NNS were_VBD done_VBN by_IN
          analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) ._. Probability_NNP values_NNS of_IN <_NN
          0_CD ._. 05_CD were_VBD considered_VBN significant_JJ ._.
        
      
      
        Results_NNS
        
          Effects_NNPS of_IN cigarette_NN smoke_NN condensate_NN on_IN cell_NN
          viability_NN and_CC apoptosis_NNS
          To_TO determine_VB the_DT effects_NNS of_IN CSC_NNP on_IN cell_NN viability_NN ,_,
          A_DT 549_CD cells_NNS and_CC NHBEs_NNP were_VBD exposed_VBN to_TO increasing_VBG
          concentrations_NNS of_IN CSC_NNP for_IN 30_CD min_NN then_RB examined_VBD using_VBG the_DT
          trypan_NN blue_JJ dye-exclusion_JJ test_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. Maximum_NNP
          toxicity_NN for_IN A_DT 549_CD at_IN the_DT highest_JJS concentration_NN of_IN CSC_NNP (_( 20_CD
          μg_NN /_NN ml_NN )_) was_VBD 15_CD %_NN ._. At_IN lower_JJR CSC_NNP concentrations_NNS (_( <_NN 0_CD ._. 1_LS
          μg_NN /_NN ml_NN )_) ,_, survival_NN was_VBD greater_JJR than_IN 90_CD %_NN for_IN both_DT A_DT 549_CD cells_NNS
          and_CC NHBEs_NNP ._. Induction_NNP of_IN apoptosis_NNS by_IN CSC_NNP was_VBD determined_VBN
          in_IN A_DT 549_CD cells_NNS and_CC NHBEs_NNP by_IN using_VBG the_DT TUNEL_NNP assay_NN and_CC
          confirmed_VBN by_IN DNA_NNP fragmentation_NN analysis_NN (_( data_NNS not_RB shown_VBN )_) ._.
          NHBEs_NNP showed_VBD 5_CD to_TO 10_CD %_NN apoptosis_NNS at_IN moderate_JJ doses_NNS of_IN CSC_NNP ;_:
          A_DT 549_CD cells_NNS showed_VBD less_JJR than_IN 5_CD %_NN apoptosis_NNS (_( Fig_NNP ._. 1_LS B_NNP )_) ._.
          However_RB ,_, with_IN increasing_VBG concentration_NN of_IN CSC_NNP ,_, NHBEs_NNP
          showed_VBD as_RB high_JJ as_IN 20_CD %_NN apoptosis_NNS ,_, while_IN A_DT 549_CD cells_NNS
          remained_VBD unchanged_JJ ._.
        
        
          Changes_NNS in_IN expression_NN of_IN specific_JJ cytokines_NNS and_CC
          chemokines_NNS after_IN exposure_NN to_TO cigarette_NN smoke_NN
          condensate_NN
          To_TO characterize_VB the_DT response_NN of_IN epithelial_NN cells_NNS to_TO
          CSC_NNP we_PRP determined_VBD the_DT changes_NNS in_IN message_NN levels_NNS for_IN a_DT
          group_NN of_IN cytokines_NNS ,_, chemokines_NNS and_CC cell-adhesion_JJ
          molecules_NNS ._. Total_NNP RNA_NNP isolated_VBD from_IN NHBEs_NNP following_VBG
          exposure_NN to_TO CSC_NNP was_VBD subjected_VBN to_TO RT-PCR_NNP ,_, and_CC the_DT results_NNS
          are_VBP shown_VBN in_IN Fig_NNP ._. 2_LS ._. IL-_NNP 1_CD β_NN was_VBD induced_VBN to_TO a_DT level_NN 9_CD ._. 5_CD
          times_NNS that_IN of_IN untreated_JJ controls_NNS ,_, while_IN the_DT expression_NN of_IN
          IL-_NNP 8_CD and_CC GM-CSF_NNP was_VBD increased_VBD 2_CD ._. 7_CD -_: fold_VB and_CC 2_CD ._. 2_CD -_: fold_VB ,_,
          respectively_RB ._. Expression_NNP of_IN the_DT adhesion_NN molecule_NN ICAM-_NNP 1_CD
          was_VBD found_VBN to_TO be_VB approximately_RB 1_CD ._. 6_CD times_NNS the_DT level_NN of_IN
          control_NN ._. IL-_NNP 6_CD and_CC the_DT chemokine_NN RANTES_NNP were_VBD elevated_VBD
          slightly_RB (_( Fig_NNP ._. 2_LS )_) ._. This_DT pattern_NN of_IN enhancement_NN of_IN
          proinflammatory_NN mediator_NN expression_NN implies_VBZ that_IN specific_JJ
          effector_NN compounds_NNS are_VBP present_JJ in_IN CSC_NNP ._.
        
        
          Involvement_NNP of_IN the_DT MAPK_NNP pathway_NN in_IN response_NN to_TO
          cigarette_NN smoke_NN condensate_NN
          To_TO examine_VB if_IN CSC-upregulation_NNP of_IN cytokine_NN production_NN
          involves_VBZ activation_NN of_IN MAPKs_NNP we_PRP examined_VBD CSC-treated_NNP
          NHBEs_NNP for_IN specific_JJ phosphorylated_JJ species_NNS ._. Fig_NNP ._. 3_LS Ashows_NNP
          the_DT results_NNS of_IN a_DT western_JJ blot_NN of_IN whole-cell_JJ extracts_NNS from_IN
          NHBEs_NNP exposed_VBD to_TO increasing_VBG concentrations_NNS of_IN CSC_NNP and_CC
          probed_JJ for_IN phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD ,_, the_DT activated_VBN form_NN of_IN
          ERK_NNP 1_CD /_NN 2_CD ._. Band_NNP densities_NNS on_IN the_DT film_NN were_VBD measured_VBN and_CC the_DT
          protein_NN loading_NN variations_NNS were_VBD adjusted_VBN by_IN normalizing_VBG
          to_TO the_DT levels_NNS of_IN non-phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD ._. The_DT level_NN of_IN
          ERK_NNP 1_CD /_NN 2_CD phosphorylation_NN increased_VBN rapidly_RB with_IN increasing_VBG
          exposure_NN to_TO CSC_NNP ,_, to_TO a_DT maximum_NN of_IN nearly_RB twice_RB the_DT
          control_NN ._. To_TO confirm_VB the_DT results_NNS of_IN immunoblot_NN detection_NN
          of_IN phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD ,_, NHBEs_NNP were_VBD exposed_VBN to_TO 0_CD ._. 4_CD μg_NN /_NN ml_NN
          CSC_NNP for_IN 30_CD min_NN ,_, then_RB fixed_VBN and_CC stained_JJ for_IN phosphorylated_JJ
          ERK_NNP 1_CD /_NN 2_CD ._. Exposure_NNP to_TO CSC_NNP caused_VBD a_DT marked_VBN increase_NN in_IN
          nuclear_JJ staining_VBG of_IN cells_NNS with_IN phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD
          antibodies_NNS (_( Fig_NNP 3_CD B_NNP )_) ._. This_DT nuclear_JJ localization_NN and_CC
          phosphorylated_JJ ERK_NNP 1_CD /_NN 2_CD staining_VBG was_VBD largely_RB blocked_VBN by_IN
          pretreating_VBG with_IN the_DT MEK_NNP inhibitor_NN PD_NNP 98059_CD ._. The_DT
          CSC-induced_NNP increase_NN in_IN IL-_NNP 1_CD β_NN expression_NN was_VBD also_RB reduced_VBN
          by_IN treatment_NN of_IN the_DT cells_NNS with_IN PD_NNP 98059_CD or_CC the_DT NFκB_NNP
          inhibitor_NN ,_, PDTC_NNP (_( Fig_NNP ._. 3_LS C_NNP )_) ._. These_DT results_NNS suggest_VBP that_IN CSC_NNP
          activates_NNS ERK_NNP 1_CD /_NN 2_CD in_IN these_DT cells_NNS within_IN 30_CD min_NN ._.
        
        
          Cigarette_NNP smoke_NN condensate_NN treatment_NN induces_VBZ rapid_JJ
          activation_NN of_IN the_DT NFκB_NNP pathway_NN
          To_TO determine_VB whether_IN upregulation_NN of_IN cytokine_NN
          production_NN by_IN CSC_NNP involved_VBD activation_NN of_IN NFκB_NNP ,_, we_PRP
          examined_VBD CSC-treated_NNP epithelial_NN cells_NNS for_IN phosphorylation_NN
          of_IN the_DT inhibitor_NN of_IN NFκB_NNP (_( IκB_NNP )_) ._. NHBEs_NNP were_VBD treated_VBN with_IN
          increasing_VBG concentrations_NNS of_IN CSC_NNP and_CC whole-cell_JJ extracts_NNS
          were_VBD immunoblotted_JJ for_IN phosphorylated_JJ IκB_NNP ._. Activation_NNP of_IN
          NFκB_NNP involves_VBZ the_DT increased_VBN phosphorylation_NN and_CC
          proteolytic_JJ degradation_NN of_IN IκB_NNP ._. Treatment_NNP of_IN cells_NNS with_IN
          increasing_VBG concentrations_NNS of_IN CSC_NNP resulted_VBD in_IN an_DT initial_JJ
          rise_NN in_IN phosphorylated_JJ IκB_NNP levels_NNS followed_VBN by_IN a_DT decrease_NN
          (_( Fig_NNP ._. 4_LS A_DT )_) ._. Protein_NNP bands_NNS were_VBD quantitated_JJ by_IN densitometry_NN
          on_IN the_DT film_NN and_CC the_DT phosphorylated_JJ IκB_NNP densities_NNS were_VBD
          normalized_JJ to_TO the_DT levels_NNS of_IN IκB_NNP ._. NHBEs_NNP exposed_VBD to_TO CSC_NNP
          also_RB showed_VBD an_DT increase_NN in_IN nuclear_JJ staining_VBG of_IN
          phosphorylated_JJ IκB_NNP as_IN detected_VBN by_IN immunocytochemical_JJ
          staining_VBG using_VBG an_DT antibody_NN to_TO phosphorylated_JJ IκB_NNP (_( Fig_NNP ._.
          4_LS B_NNP )_) ._.
        
        
          Effect_NN of_IN cigarette_NN smoke_NN condensate_NN on_IN
          transcriptional_NN activation_NN of_IN luciferase_NN reporter_NN
          construct_VB
          CSC_NNP appears_VBZ to_TO activate_VBP NFκB_NNP ,_, which_WDT should_MD result_VB in_IN
          transcriptional_NN activation_NN of_IN NFκB-inducible_NNP genes_NNS ._.
          Therefore_RB ,_, A_DT 549_CD cells_NNS were_VBD transfected_JJ with_IN a_DT luciferase_NN
          reporter_NN plasmid_NN containing_VBG a_DT promoter_NN sequence_NN that_WDT
          bound_VBN NFκB_NNP and_CC luciferase_NN activity_NN was_VBD measured_VBN after_IN
          challenge_NN with_IN CSC_NNP ._. Treatment_NNP with_IN 0_CD ._. 4_CD μg_NN /_NN ml_NN CSC_NNP for_IN 30_CD
          min_NN resulted_VBD in_IN significant_JJ enhancement_NN of_IN luciferase_NN
          reporter_NN expression_NN compared_VBN to_TO control_VB (_( Fig_NNP ._. 4_LS C_NNP )_) ,_,
          indicating_VBG activation_NN of_IN NFκB_NNP ._. TNF-α_NNP used_VBD as_IN a_DT positive_JJ
          control_NN also_RB activated_VBN luciferase_NN gene_NN expression_NN with_IN
          the_DT same_JJ plasmid_NN system_NN ._. Exposure_NNP of_IN cells_NNS transfected_JJ
          with_IN the_DT reporter_NN plasmid_NN to_TO increasing_VBG doses_NNS of_IN CSC_NNP
          showed_VBD NFκB_NNP expression_NN peaking_VBG at_IN a_DT CSC_NNP concentration_NN
          between_IN 1_CD and_CC 4_CD μg_NN /_NN ml_NN (_( Fig_NNP ._. 4_LS D_NNP )_) ._.
        
      
      
        Discussion_NNP
        The_DT complex_JJ changes_NNS in_IN lung_NN function_NN ,_, morphology_NN ,_, and_CC
        gene_NN expression_NN caused_VBN by_IN compounds_NNS in_IN cigarette_NN smoke_NN
        involve_VBP a_DT combination_NN of_IN direct_JJ and_CC indirect_JJ effects_NNS on_IN
        cells_NNS ,_, but_CC principally_RB center_NN around_IN an_DT increase_NN in_IN airway_NN
        inflammation_NN as_IN a_DT result_NN of_IN cigarette_NN smoking_NN ._. The_DT results_NNS
        of_IN our_PRP$ studies_NNS demonstrate_VBP that_IN the_DT mechanism_NN underlying_VBG
        these_DT acute_JJ inflammatory_JJ events_NNS involves_VBZ activation_NN of_IN
        specific_JJ signaling_VBG pathways_NNS such_JJ as_IN MAPK_NNP (_( ERK_NNP 1_CD /_NN 2_LS )_) and_CC NFκB_NNP ,_,
        leading_VBG to_TO the_DT release_NN of_IN proinflammatory_NN cytokines_NNS ._.
        One_CD of_IN the_DT important_JJ observations_NNS of_IN this_DT study_NN is_VBZ the_DT
        effect_NN of_IN CSC_NNP on_IN NHBEs_NNP ._. Even_RB at_IN a_DT concentration_NN of_IN 0_CD ._. 4_CD
        μg_NN /_NN ml_NN ,_, which_WDT does_VBZ not_RB induce_VB significant_JJ changes_NNS in_IN the_DT
        viability_NN of_IN these_DT cells_NNS ,_, CSC_NNP induced_VBD increases_NNS in_IN
        expression_NN of_IN several_JJ cytokines_NNS at_IN the_DT mRNA_NN level_NN ._. IL-_NNP 1_CD β_NN ,_,
        which_WDT was_VBD significantly_RB upregulated_JJ in_IN NHBEs_NNP following_VBG CSC_NNP
        exposure_NN ,_, has_VBZ been_VBN shown_VBN to_TO be_VB important_JJ for_IN activation_NN of_IN
        IL-_NNP 8_CD [_NN 6_CD ]_NN and_CC ICAM-_NNP 1_CD [_NN 4_CD ]_NN ._. This_DT is_VBZ also_RB consistent_JJ with_IN
        the_DT report_NN that_IN epithelial_NN cells_NNS regulate_VB inflammatory_JJ
        events_NNS by_IN secreting_VBG cytokines_NNS and_CC chemokines_NNS such_JJ as_IN IL-_NNP 1_CD β_NN ,_,
        IL-_NNP 8_CD ,_, GM-CSF_NNP ,_, TNF-α_NNP ,_, and_CC sICAM-_NN 1_CD [_NN 2_CD ]_NN ._. These_DT paracrine_NN
        effectors_NNS can_MD then_RB produce_VB further_JJ primary_JJ local_JJ
        inflammation_NN or_CC amplify_VB the_DT effects_NNS of_IN previously_RB activated_VBN
        macrophages_NNS ,_, eosinophils_NNS ,_, mast_NN cells_NNS ,_, or_CC lymphocytes_NNS ._. A_DT
        notable_JJ finding_NN from_IN our_PRP$ study_NN is_VBZ that_DT exposure_NN of_IN NHBEs_NNP to_TO
        CSC_NNP elicits_NNS the_DT synthesis_NN and_CC release_NN of_IN a_DT pattern_NN of_IN
        mediators_NNS similar_JJ to_TO that_DT seen_VBN in_IN A_DT 549_CD cells_NNS in_IN response_NN to_TO
        CSC_NNP ._. These_DT results_NNS imply_VBP that_IN neoplastic_JJ cells_NNS and_CC normal_JJ
        cells_NNS respond_VBP to_TO CSC_NNP in_IN a_DT similar_JJ manner_NN ._.
        Cigarette_NNP smoke_NN has_VBZ been_VBN shown_VBN by_IN others_NNS to_TO induce_VB a_DT
        synthesis_NN of_IN glutathione_NN and_CC gamma-glutamylcysteine_JJ that_WDT
        was_VBD associated_VBN with_IN transcription_NN factor_NN AP-_NNP 1_CD or_CC an_DT
        AP-_NNP 1_CD -_: like_IN response_NN element_NN [_NN 9_CD ]_NN ._. Although_IN MAPKs_NNP and_CC NFκB_NNP
        have_VBP been_VBN implicated_VBN in_IN the_DT upregulation_NN of_IN proinflammatory_NN
        cytokines_NNS ,_, the_DT role_NN of_IN these_DT pathways_NNS in_IN normal_JJ human_JJ
        pulmonary_JJ epithelial_NN cells_NNS in_IN response_NN to_TO CSC_NNP has_VBZ not_RB been_VBN
        investigated_VBN ._. The_DT results_NNS of_IN our_PRP$ study_NN implicate_VB the_DT ERK_NNP 1_CD /_NN 2_CD
        (_( p_NN 42_CD /_NN 44_CD )_) MAPK_NNP pathway_NN as_IN a_DT key_JJ element_NN in_IN this_DT inflammatory_JJ
        response_NN ,_, an_DT association_NN that_WDT has_VBZ not_RB heretofore_RB been_VBN
        reported_VBN in_IN normal_JJ human_JJ pulmonary_JJ epithelial_NN cells_NNS ._. A_DT
        significant_JJ finding_NN of_IN this_DT study_NN is_VBZ that_IN MAPKs_NNP such_JJ as_IN
        ERK_NNP 1_CD /_NN 2_CD (_( p_NN 44_CD /_NN p_NN 42_CD )_) are_VBP consistently_RB activated_VBN in_IN NHBEs_NNP ._.
        However_RB ,_, upon_IN exposure_NN to_TO CSC_NNP ,_, the_DT magnitude_NN of_IN
        phosphorylation_NN increases_NNS ._. The_DT finding_VBG that_IN IL-_NNP 1_CD β_NN
        expression_NN and_CC MAPK_NNP activation_NN are_VBP concomitantly_RB increased_VBN
        by_IN CSC_NNP exposure_NN and_CC inhibited_VBD by_IN PD_NNP 98059_CD is_VBZ consistent_JJ with_IN
        the_DT report_NN that_IN MAPKs_NNP activate_VBP expression_NN of_IN IL-_NNP 1_CD β_NN genes_NNS [_NN
        10_CD ]_NN ._. Although_IN the_DT control_NN of_IN cytok-_NN 80_CD %_NN confluence_NN on_IN
        12_CD -_: well_RB plates_NNS and_CC transfected_JJ with_IN the_DT Mercury_NNP pathway_NN
        profiling_VBG system_NN vector_NN ,_, pNFκB-TA-Luc_JJ (_( Clontech_NNP ,_, Palo_NNP Alto_NNP ,_,
        CA_NNP ,_, USA_NNP )_) ,_, using_VBG lipofectamine_NN (_( Gibco_NNP /_NN BRL_NNP ,_, Rockville_NNP ,_, MD_NNP ,_,
        USA_NNP )_) and_CC used_VBN according_VBG to_TO the_DT manufacturer_NN 's_POS
        recommendations_NNS ._. Cells_NNP were_VBD transfected_JJ using_VBG lipofectamine_NN
        from_IN Bibco_NNP /_NN BRL_NNP (_( Rockville_NNP ,_, MD_NNP )_) ._. The_DT plasmid_NN ,_, pVAX-LacZ_JJ ,_,
        (_( Clontech_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP ,_, USA_NNP )_) was_VBD used_VBN as_IN transfection_NN
        control_NN ._.
        DNA_NN /_NN lipofectamine_NN complexes_NNS were_VBD allowed_VBN to_TO form_VB for_IN 30_CD
        min_NN at_IN room_NN temperature_NN in_IN RPMI_NNP (_( without_IN antibiotics_NNS )_)
        containing_VBG 1_CD μg_NN of_IN reporter_NN plasmid_NN ,_, 20_CD ng_NN of_IN pVAX-LacZ_JJ for_IN
        monitoring_VBG transfection_NN efficiency_NN ,_, and_CC 10_CD μg_NN of_IN
        lipofectamine_NN ._. Cells_NNP were_VBD transfected_JJ for_IN 18_CD h_NN ._. Prior_RB to_TO
        CSC_NNP challenge_NN ,_, the_DT transfected_JJ cells_NNS were_VBD preincubated_JJ for_IN
        4_CD hours_NNS in_IN minimal_JJ Eagle_NNP 's_POS medium_NN with_IN Earle_NNP 's_POS salts_NNS to_TO
        remove_VB serum_NN factors_NNS ._. Assays_NNP were_VBD done_VBN in_IN triplicate_NN and_CC
        consisted_VBD of_IN untreated_JJ controls_NNS ,_, treatment_NN with_IN 50_CD ng_NN /_NN ml_NN
        TNF-α_NNP and_CC treatment_NN with_IN 0_CD ._. 4_CD μg_NN /_NN ml_NN CSC_NNP ._. After_IN treatments_NNS ,_,
        the_DT cells_NNS were_VBD lysed_JJ by_IN addition_NN of_IN cell_NN lysis_NNS buffer_NN as_IN
        supplied_VBN in_IN the_DT luciferase_NN assay_NN kit_NN from_IN Clontech_NNP ,_, scraped_JJ
        from_IN the_DT wells_NNS and_CC centrifuged_JJ 1_CD min_NN at_IN 12_CD ,_, 000_CD ×_NN 
        g_SYM ._. Aliquots_NNP of_IN 20_CD μl_NN of_IN each_DT lysate_NN
        were_VBD transferred_VBN to_TO flat-bottomed_JJ ,_, white_JJ microtiter_NN plates_NNS
        (_( Dynex_NNP ,_, Chantilly_NNP ,_, VA_NNP ,_, USA_NNP )_) and_CC read_VB on_IN a_DT Dynex_NNP MLX_NNP plate_NN
        reader_NN in_IN flash_VBP mode_NN ._. The_DT transfection_NN efficiency_NN was_VBD
        normalized_JJ by_IN determining_VBG β-galactosidase_JJ activity_NN in_IN the_DT
        lysates_NNS from_IN the_DT cotransfected_JJ pLacZ_NN plasmid_NN ._.
      
      
        Conclusion_NNP
        In_IN essence_NN ,_, these_DT results_NNS demonstrate_VBP that_IN NHBEs_NNP respond_VBP
        to_TO moderate_JJ doses_NNS of_IN CSC_NNP by_IN activating_VBG both_DT the_DT ERK_NNP 1_CD /_NN 2_CD and_CC
        the_DT NFκB_NNP pathways_NNS ,_, and_CC by_IN upregulating_VBG the_DT expression_NN of_IN
        several_JJ genes_NNS encoding_VBG proinflammatory_NN molecules_NNS ._.
      
      
        Abbreviations_NNP
        BSA_NNP =_SYM Bovine_NNP serum_NN albumin_NN ;_: CSC_NNP =_SYM cigarette_NN smoke_NN
        condensate_NN ;_: ERK_NNP =_SYM extracellular_NN signal-regulated_JJ kinase_NN ;_:
        GM-CSF_NNP =_SYM granulocyte-macrophage_JJ colony-stimulating_JJ factor_NN ;_:
        HBE_NNP =_SYM human_JJ bronchial_NN epithelial_NN cell_NN ;_: IL_NNP =_SYM interleukin_NN ;_:
        IκB_NNP =_SYM inhibitor_NN of_IN NFκB_NNP ;_: MAPK_NNP =_SYM mitogen-activated_JJ protein_NN
        kinase_NN ;_: MEK-_NNP 1_CD =_SYM MAPK_NNP kinase_NN ;_: NFκB_NNP =_SYM nuclear_JJ factor-kappa_JJ B_NNP ;_:
        NHBE_NNP =_SYM normal_JJ human_JJ bronchial_NN epithelial_NN cell_NN ;_: PBS_NNP =_SYM
        phosphate-buffered_JJ saline_NN ;_: PDTC_NNP =_SYM pyrrolidine_NN
        dithiocarbamate_NN ;_: RT-PCR_NNP =_SYM reverse_VB transcriptase-polymerase_JJ
        chain_NN reaction_NN ;_: sICAM_NN =_SYM soluble_JJ intercellular_NN adhesion_NN
        molecule_NN ;_: TNF_NNP =_SYM tumour_NN necrosis_NNS factor_NN ;_: TUNEL_NNP =_SYM
        deoxynucleotidyl_NN transferase-mediated_JJ dUTP_NN nick_NN end_NN
        labeling_VBG
      
    
  
